Home > Riviste > Minerva Medica > Fascicoli precedenti > Minerva Medica 2016 February;107(1) > Minerva Medica 2016 February;107(1):70-6

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti
Per citare questo articolo

MINERVA MEDICA

Rivista di Medicina Interna


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,878


eTOC

 

REVIEWS  


Minerva Medica 2016 February;107(1):70-6

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

Long noncoding RNA GAS5 can predict metastasis and poor prognosis: a meta-analysis

Wei SONG, Kai WANG, Run-Jin ZHANG, Qi-Xin DAI, Shu-Bing ZOU

Department of Hepatobiliary Surgery, The Second affiliated hospital of Nanchang University, Nanchang, China


PDF  


INTRODUCTION: Growth arrest-specific 5 (GAS5), a newly discovered long-noncoding RNAs (lncRNAs), has been reported to be down-regulated in multiple cancers. This meta-analysis aims to identify the potential value of GAS5 as a biomarker of cancer metastasis and prognosis.
EVIDENCE ACQUISITION: We searched the MEDLINE, EMBASE and Cochrane Library databases. This meta-analysis collected all relevant studies and explored the association of lncRNA GAS5 with overall survival (OS), lymphnode metastasis (LNM), and distant metastasis (DM).
EVIDENCE SYNTHESIS: Four studies were eligible for analysis, which included 328 patients. Meta-analysis revealed that low levels of GAS5 expression could predict poor OS in multiple cancers (pooled Hazard Ratio [HR]: 0.38, 95% confidence interval [CI]: 0.26-0.54, P<0.00001). Moreover, compared with high GAS5 expression, low GAS5 expression was correlated with LNM (pooled HR: 4.03, 95% CI: 1.93-8.41, P=0.0002) and DM (pooled HR: 10.17, 95% CI: 1.26-82.31, P=0.03).
CONCLUSIONS: lncRNA GAS5 may potentially serve as a novel biomarker for cancer metastasis and prognosis.

inizio pagina

Publication History

Per citare questo articolo

Song W, Wang K, Zhang RJ, Dai QX, Zou SB. Long noncoding RNA GAS5 can predict metastasis and poor prognosis: a meta-analysis. Minerva Med 2016 February;107(1):70-6. 

Corresponding author e-mail

tofsw@sina.com